Regeneron Adds Hearing Loss Gene Therapy Program Via Decibel Therapeutics Acquisition
Regeneron Pharmaceuticals completed its acquisition of Decibel Therapeutics, strengthening the company’s gene therapy and auditory programs.
Regeneron Pharmaceuticals completed its acquisition of Decibel Therapeutics, strengthening the company’s gene therapy and auditory programs.